{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T06:47:40Z","timestamp":1776062860684,"version":"3.50.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Transplant."],"abstract":"<jats:p>Sri Lanka's kidney transplantation programme has matured within a resource-constrained public health system and has achieved short-term outcomes that appear comparable to published ranges from similar middle-income programmes, despite major limitations in real-time transplant immunobiology support. However, increasing recipient sensitisation, prolonged dialysis vintage, and a growing deceased-donor programme demand more reliable immunological risk assessment to improve equity and graft outcomes. This pragmatic narrative review summarises the minimum immunobiology package that can support safer kidney transplantation in low- and middle-income settings, using Sri Lanka as an example. Key concepts are explained in simple operational terms, including sensitisation and antibody screening (PRA, including the Zora assay), single-antigen bead testing and donor-specific antibody interpretation, practical use and limitations of virtual crossmatch when donor HLA data are incomplete, and the continuing role of CDC crossmatch where flow-cytometry crossmatch is unavailable. The review also highlights why unexpected early rejection may still occur even when HLA-based testing appears reassuring, and why over-reliance on any single assay can be misleading. Finally, a staged roadmap is proposed\u2014prioritising feasible upgrades, quality assurance, workforce development, and national coordination\u2014to progressively strengthen transplant immunobiology while preserving affordability, fairness, and sustainability. This is a pragmatic narrative review informed by consensus guidance and key peer-reviewed literature, synthesised to prioritise actionable, scalable immunobiology components for low- and middle-income settings.<\/jats:p>","DOI":"10.3389\/frtra.2026.1772174","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:49:09Z","timestamp":1776059349000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Building pragmatic transplant immunobiology in Sri Lanka: a concise review with an LMIC lens"],"prefix":"10.3389","volume":"5","author":[{"given":"Anura Priyantha","family":"Hewageegana","sequence":"first","affiliation":[{"name":"Division of Nephrology, National Hospital of Sri Lanka","place":["Colombo, Sri Lanka"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1056\/NEJMra1802677","article-title":"Antibody-mediated rejection of solid-organ allografts","volume":"379","author":"Loupy","year":"2018","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1111\/ajt.12807","article-title":"HLA antibody detection with solid phase assays: great expectations or expectations too great?","volume":"14","author":"Gebel","year":"2014","journal-title":"Am J Transplant"},{"key":"B4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/ajt.14107","article-title":"The Banff 2015 kidney meeting report: current challenges in rejection classification and prospects for adopting molecular pathology","volume":"17","author":"Loupy","year":"2017","journal-title":"Am J Transplant"},{"key":"B5","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"B6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1600-6143.2009.02927.x","article-title":"Calculated PRA (CPRA): the new measure of sensitization for transplant candidates","volume":"10","author":"Cecka","year":"2010","journal-title":"Am J Transplant"},{"key":"B7","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1097\/TP.0000000000000657","article-title":"Inclusion of DQA, DPA, and DPB increases cPRA estimates in sensitized patients","volume":"99","author":"Tambur","year":"2015","journal-title":"Transplantation"},{"key":"B8","volume-title":"Calculated Panel Reactive Antibody (cPRA) Calculation Update to Include DQA1, DPA1, DPB1 and Allele-level antibodies (implemented January 26, 2012)","year":"2012"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1111\/j.1600-6143.2009.02761.x","article-title":"Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining","volume":"9","author":"Sis","year":"2009","journal-title":"Am J Transplant"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1111\/ajt.12465","article-title":"Microarray-based diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM)","volume":"13","author":"Halloran","year":"2013","journal-title":"Am J Transplant"},{"key":"B11","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/TP.0b013e3181e2c5a5","article-title":"Microarray-based molecular assessment of renal allograft pathology","volume":"90","author":"Halloran","year":"2010","journal-title":"Transplantation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nrneph.2017.95","article-title":"The molecular diagnosis of rejection in kidney transplants","volume":"13","author":"Halloran","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1215555","article-title":"Urinary-cell mRNA profile and acute cellular rejection in kidney allografts","volume":"369","author":"Suthanthiran","year":"2013","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.kint.2022.02.019","article-title":"Principles of virtual crossmatch testing for kidney transplantation","volume":"101","author":"Bhaskaran","year":"2022","journal-title":"Kidney Int"},{"key":"B15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11886-015-0602-4","article-title":"Application and interpretation of histocompatibility data in thoracic (and extension to solid organ) transplantation","volume":"17","author":"Schlendorf","year":"2015","journal-title":"Curr Cardiol Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.3390\/jcm11144143","article-title":"Non-HLA antibodies in kidney transplantation: pathophysiology and clinical implications","volume":"11","author":"Sorohan","year":"2022","journal-title":"J Clin Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1681\/ASN.2018070737","article-title":"Complement-binding donor-specific anti-HLA antibodies and outcomes in kidney transplantation","volume":"30","author":"Sigurj\u00f3nsd\u00f3ttir","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1097\/TP.0000000000000707","article-title":"Assessing antibody strength: comparison of MFI, C1q, and C3d assays in predicting antibody-mediated rejection","volume":"99","author":"Tambur","year":"2015","journal-title":"Transplantation"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1097\/TP.0000000000001203","article-title":"Interpreting anti-HLA antibody testing data: a practical guide for physicians","volume":"100","author":"Schinstock","year":"2016","journal-title":"Transplantation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/ajt.14229","article-title":"The road to HLA antibody evaluation: do not rely on MFI","volume":"17","author":"Sullivan","year":"2017","journal-title":"Am J Transplant"},{"key":"B21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.humimm.2018.02.001","article-title":"Virtual crossmatch for deceased donor kidney transplantation\u2014practical considerations","volume":"79","author":"Puttarajappa","year":"2018","journal-title":"Hum Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/ajt.12287","article-title":"Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA","volume":"13","author":"Reed","year":"2013","journal-title":"Am J Transplant"},{"key":"B23","doi-asserted-by":"publisher","first-page":"416","DOI":"10.4103\/ijn.IJN_76_17","article-title":"Donor-specific antibody detection by single-antigen bead assay for renal transplantation: experience from an Indian center","volume":"28","author":"Neeraja","year":"2018","journal-title":"Indian J Nephrol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.transproceed.2019.02.062","article-title":"Evaluation of screening tests for pre-transplant compatibility testing: an algorithmic approach for resource-limited settings","volume":"51","author":"Chauhan","year":"2019","journal-title":"Transplant Proc"},{"key":"B25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4103\/ijn.IJN_257_18","article-title":"Prevalence and specificity of preformed anti-HLA antibodies detected by luminex single-antigen bead assay in renal transplant candidates in north India","volume":"30","author":"Chauhan","year":"2020","journal-title":"Indian J Nephrol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000351459","article-title":"Luminex and its applications for solid-organ transplantation, haematopoietic stem cell transplantation, and transfusion","volume":"40","author":"Lachmann","year":"2013","journal-title":"Transfus Med Hemother"},{"key":"B27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/MOT.0000000000000326","article-title":"Clinically relevant interpretation of solid-phase assays for HLA antibody","volume":"21","author":"Bettinotti","year":"2016","journal-title":"Curr Opin Organ Transplant"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e22237","DOI":"10.1002\/jcla.22237","article-title":"False-negative single-antigen bead assay: is it always prozone?","volume":"32","author":"Mishra","year":"2018","journal-title":"J Clin Lab Anal"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1111\/ajt.14303","article-title":"EDTA Treatment unmasks complement-mediated prozone inhibition in HLA antibody testing","volume":"17","author":"Anani","year":"2017","journal-title":"Am J Transplant"},{"key":"B30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/ajt.14128","article-title":"OPTN\/SRTR 2015 annual data report: kidney","volume":"17","author":"Hart","year":"2017","journal-title":"Am J Transplant"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1111\/ajt.15898","article-title":"The Banff 2019 kidney meeting report (I): updates on and clarification of criteria for T cell- and antibody-mediated rejection","volume":"20","author":"Loupy","year":"2020","journal-title":"Am J Transplant"},{"key":"B32","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ajt.2023.10.016","article-title":"The Banff 2022 kidney meeting report: reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics","volume":"24","author":"Naesens","year":"2024","journal-title":"Am J Transplant"},{"key":"B33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ajt.2022.11.013","article-title":"Clinical recommendations for posttransplant assessment of anti-HLA donor-specific antibodies: a sensitization in transplantation: assessment of risk consensus document","volume":"23","author":"Lefaucheur","year":"2023","journal-title":"Am J Transplant"}],"container-title":["Frontiers in Transplantation"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frtra.2026.1772174\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:49:15Z","timestamp":1776059355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frtra.2026.1772174\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":33,"alternative-id":["10.3389\/frtra.2026.1772174"],"URL":"https:\/\/doi.org\/10.3389\/frtra.2026.1772174","relation":{},"ISSN":["2813-2440"],"issn-type":[{"value":"2813-2440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"article-number":"1772174"}}